Key result
Early VA-ECMO, IABP, and immunotherapy achieve full recovery in fulminant myocarditis cardiogenic shock.
Why the study?
Does the combination of mechanical circulatory support and immunological modulation improve survival in a young patient with fulminant myocarditis and cardiogenic shock?
Case Report (n=1)
No
Does the combination of mechanical circulatory support and immunological modulation improve survival in a young patient with fulminant myocarditis and cardiogenic shock?
Early utilization of VA-ECMO and IABP coupled with immunomodulation can rapidly reverse fatal cardiogenic shock secondary to fulminant myocarditis.
Answers are grounded in this paper and cite their sources.
Supports combined MCS and immunomodulation in fulminant myocarditis shock; hypothesis-generating and requires prospective trials before practice change.
Background: Severe heart failure or cardiogenic shock might arise as a consequence of fulminant myocarditis if it manifests and advances swiftly. The effective implementation of an immunological modulation regimen and mechanical circulatory support has proven instrumental in preserving the lives of individuals experiencing hemodynamic disturbance. Case Presentation: The current report described a severe instance of fulminant myocarditis in an 18-year-old young woman who presented with severe hypoxemia and hemodynamic instability. The patient was treated with a combination of optimal medical therapy, immunological modulation, extracorporeal membrane oxygenation (ECMO), and an intra-aortic balloon pump (IABP) to support him through his critical period of hemodynamic collapse. Conclusion: The case presented herein underscored the prompt reversal of life-threatening fulminant myocarditis subsequent to a comprehensive treatment regimen encompassing optimal medical therapy and aggressive mechanical circulatory support.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2024) conducted a case report in Fulminant myocarditis with cardiogenic shock (n=1). VA-ECMO, IABP, and immunological modulation was evaluated on Clinical recovery and survival. The prompt implementation of VA-ECMO and IABP alongside immunological modulation successfully reversed cardiogenic shock and life-threatening fulminant myocarditis, resulting in full recovery.
Synapse has enriched 10 related papers. Consider them for comparative context: